Young Mee Cho

10PUBLICATIONS
34CO-AUTHORS
Molecular targetsPathology (excl. oral pathology)Predictive and prognostic markersTransplantation immunologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 10, 2024
IFITM3-mediated activation of TRAF6/MAPK/AP-1 pathways induces acquired TKI resistance in clear cell renal cell carcinoma.

Se Un Jeong, Ja-Min Park, Sun Young Yoon

|Nov 08, 2021
Clinico-cytopathologic analysis of 574 Pericardial Effusion Specimens: Application of the international system for reporting serous fluid cytopathology (ISRSFC) and long-term clinical follow-up.

Min Jeong Song, Uiree Jo, Ji-Seon Jeong

|Feb 08, 2020
Involvement of the TNF-α Pathway in TKI Resistance and Suggestion of TNFR1 as a Predictive Biomarker for TKI Responsiveness in Clear Cell Renal Cell Carcinoma.

Hee Sang Hwang, Yun Yong Park, Su Jin Shin

|Jan 19, 2020
Recurrent KRAS mutations identified in papillary renal neoplasm with reverse polarity-a comparative study with papillary renal cell carcinoma.

Sung Sun Kim, Yong Mee Cho, Gi Hwan Kim

|Nov 14, 2019
CD56<sup>+</sup>CD57<sup>+</sup> infiltrates as the most predominant subset of intragraft natural killer cells in renal transplant biopsies with antibody-mediated rejection.

Hey Rim Jung, Mi Joung Kim, Yu-Mee Wee

|Nov 12, 2019
Phosphorylation of TFCP2L1 by CDK1 is required for stem cell pluripotency and bladder carcinogenesis.

Jinbeom Heo, Byeong-Joo Noh, Seungun Lee

Pageof 2

Frequent Collaborators

2 joint publications

Jae-Lyun Lee

2 joint publications

Sun Young Yoon

2 joint publications

Dong-Myung Shin

2 joint publications

Ja-Min Park